@aga-gihn.bsky.social
170 followers 120 following 100 posts
Posts Media Videos Starter Packs
Pinned
aga-gihn.bsky.social
Happy September! ✏️🍎 Be sure to check out this month's new issue, including:
✔️Member spotlight on Dr. Jessica Korman
✔️5 tips on becoming a GI consultant by
✔️Colonoscopy screening effective in 45- to 49-year-olds

Read more: ow.ly/LJeT50WPzkH
aga-gihn.bsky.social
In this video from The New Gastroenterologist and DHPA, Dr. Peter Naas shares advice for young GIs starting a career in private practice gastroenterology. 🎥 Watch now: ow.ly/NSlx50WNKMj
aga-gihn.bsky.social
To be an effective #GI consultant, Dr. Allon Kahn advises being the following 5️⃣ things: kind, timely, specific, helpful and honest.

Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV
aga-gihn.bsky.social
More than 10% of GIs may face a malpractice claim, but it’s rarely discussed in med school. For The New Gastroenterologist, Dr. Koushik Das explains what malpractice is, the timeline of a lawsuit, and other consequences you might need to know. 👉 ow.ly/YaO950WNKJh
aga-gihn.bsky.social
In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care.

🔗 Read more: ow.ly/gMiq50WRtGz
aga-gihn.bsky.social
#GLP1 has become a cornerstone in diabetes in weight loss management. For The New Gastroenterologist, Dr. Nikiya Asamoah & Dr. Sitharthan Sekar review current evidence and guidelines for GLP-1 use for endoscopic procedures ➡️ ow.ly/nZet50WNKHC
aga-gihn.bsky.social
Exocrine pancreatic insufficiency is a challenging diagnosis. In this month’s In Focus, review how to approach diagnosing and treating EPI, plus screening for complications. www.mdedge.com/gihepnews/ar...
aga-gihn.bsky.social
The latest issue of The New Gastroenterologist is live! In this issue, we cover exocrine pancreatic insufficiency, GLP-1 use, medical malpractice lawsuits and more. ow.ly/40bJ50WNKEQ
aga-gihn.bsky.social
🖤 Ready to be inspired and uplifted? #ABGHNexus2025 is bringing together Black women in medicine for an unforgettable experience Oct. 3–5 at The Times Center, NYC! Join ABGH for connection, growth, and empowerment—register by Sept. 19 to save! #BlackWomenInMedicine whova.com/portal/regis...
aga-gihn.bsky.social
Our September member spotlight is @jessicakormanmd.bsky.social, whose mission is to reduce the stigma around anal cancer.

“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc
aga-gihn.bsky.social
New #IBS in America survey reveals that IBS symptoms continue to disrupt lives — an average of 19 days each month. ow.ly/5Ij650WOeEK
aga-gihn.bsky.social
A new @aga-gastro.bsky.social clinical practice update, published in @aga-cgh.bsky.social, offers guidance for identifying GI symptoms in patients with hypermobile Ehlers-Danlos syndrome. ➡️ ow.ly/NsGz50WNKtq
aga-gihn.bsky.social
Happy September! ✏️🍎 Be sure to check out this month's new issue, including:
✔️Member spotlight on Dr. Jessica Korman
✔️5 tips on becoming a GI consultant by
✔️Colonoscopy screening effective in 45- to 49-year-olds

Read more: ow.ly/LJeT50WPzkH
aga-gihn.bsky.social
Follow-up colonoscopies are low after blood-based CRC screening, raising concerns about missed diagnoses. New research led by Dr. Timothy Zaki in @aga-gastro.bsky.social highlights the need for better patient education and system-level interventions. ➡️
Follow-Up Colonoscopies Low After Blood-Based Screening | MDedge
People receiving blood-based colorectal screening tests showed disappointingly low rates of receiving follow-up colonoscopies that are essential when tests are
ow.ly
aga-gihn.bsky.social
🚫🔗 New study in @aga-cgh.bsky.social shows no association between IBD medications and breast cancer recurrence, even among patients receiving anti-TNF agents or immunomodulators.

Dr. Mahadevan weighs in on the clinical implications. Read more:
IBD Medications Show No Link with Breast Cancer Recurrence | MDedge
Medications for inflammatory bowel disease (IBD) appear to have no impact on risk of incident malignancies among patients with a history of breast cancer
ow.ly
aga-gihn.bsky.social
New review from @jama.com: Early onset #GI cancers are rising worldwide, calling for enhanced prevention strategies. Read more about what challenges this creates for treatment and the importance of early detection: 🔗
Alarming Rise in Early-Onset GI Cancers Calls for Early Screening, Lifestyle Change | MDedge
Early-onset gastrointestinal (GI) cancers diagnosed before age 50 are rising at alarming rates worldwide, underscoring the need for enhanced prevention strategi
ow.ly
aga-gihn.bsky.social
Our August member spotlight features none other than our @amergastroassn.bsky.social president Dr. Larry Kim! Read about his goals for AGA, advice for aspiring med students and more: www.mdedge.com/gihepnews/ar...
aga-gihn.bsky.social
A study from @aga-ghadvances.bsky.social found that endoscopists can safely forgo sterile water for tap, reducing environmental and financial costs. Check out our summary, with commentary from Dr. Seth A. Gross on what this might mean for you: ow.ly/Bw9f50WAbzj
aga-gihn.bsky.social
📰 Our August issue is live! In this month's paper:
⭐Member spotlight on @amergastroassn.bsky.social President Dr. Larry Kim
⭐In Focus column on #EPI
⭐Practical tips for delivering feedback

and more! Read the full issue: cdn.mdedge.com/files/s3fs-p...
aga-gihn.bsky.social
Can response to anti-obesity medicines be predicted? With phenotype-based testing, new research says yes (but it's complicated). ow.ly/t7hb50Wxkm2

“Obesity is not a single disease. It’s a complex, multifactorial condition driven by diverse biological pathways.” — Dr. Andres Acosta
Can Nonresponders to Antiobesity Medicines Be Predicted? | MDedge
Emerging research indicates that phenotype-based testing may help identify which biologic process is driving an individual’s obesity
ow.ly
aga-gihn.bsky.social
A study published in @thelancet.com found a less invasive sponge test could be used instead of endoscopy for Barrett's esophagus surveillance. ow.ly/vAze50WxkcQ
aga-gihn.bsky.social
🧠A new global study from @aga-gastro.bsky.social shows AI can predict outcomes in hospitalized cirrhosis patients — and it beats traditional methods.

Read more here: gastro.org/news/ai-serv...

#GIsky #AI #Liverdisease #Cirrhosis
aga-gihn.bsky.social
Sclerosing mesenteritis: what do GIs need to know about this rare disease? A recent @amergastroassn.bsky.social clinical practice update offers guidance on diagnosing and treating the condition and a roadmap for future research. ➡️https://ow.ly/eOa250WrO7M
aga-gihn.bsky.social
In our July Perspectives column, we offer two different viewpoints on lower GI bleeding. GI hospitalist Dr. Wan & Dr. Lee share a pragmatic approach based on clinical patterns, while Dr. Metwalli highlights his perspective as an interventional radiologist. www.mdedge.com/gihepnews/ar...